MDNews - Lower Hudson/Bronx

August/September 2021

Issue link: https://viewer.e-digitaledition.com/i/1429589

Contents of this Issue

Navigation

Page 9 of 23

and the graf t will persist and sur vive," Dr. Genden says. " We wa nted to have a ma le a nd a fema le because we ca n, through the use of cy togenetics, demon- strate with biopsies what percent of the g ra f t seg ment is his donor tissue a nd what percent is hers. That 's been a n important part of the research." THE MOMENT OF TRUTH By January, all the pieces finally fell into place. However, even after the potential donor arrived, Dr. Genden and his team needed to ensure they could procure the trachea and all the necessary blood vessels. To do this, they performed a preparation surgery, exposing the tra- chea, thyroid gland, arteries and blood vessels to determine whether the graft was viable. Seeing that the vessels were well-defined and the length of the trachea was sufficient, they made the decision to move forward and bring Sein into the operating room. After removing the diseased windpipe and preparing Sein's blood vessels for microvascular transfer, the surgical team placed the donor graft on ice. While this is a critical time in any transplant surgery, the team felt the pressure more than ever, because the organ being transplanted was without blood supply and they had no way of knowing how well the graft would adapt without it. As quickly as possible, the team put the graft in and revascularized it, connecting the arteries and the vein. "In 25 to 28 years of practicing head and neck surgery, there was probably nothing more exciting than releasing the blood vessels and watching the graft actually come alive and the entire length of the trachea, all the way down to the lung, bleed, which means it's alive and it's well vascularized," Dr. Genden said in the video. A NEW CHANCE FOR LIFE The outcome of the 18-hour surgery was beyond anyone's greatest expectations. "If I could have written it to go as well as it could have, I don't think anyone would have believed it," Dr. Genden says. "It went very, very smoothly, and I was more surprised than anyone. I was prepared for any number of issues to come up." Because organ rejection was a major risk after the surgery, Dr. Genden and Dr. Florman developed a new immunology regimen to give the transplanted trachea the best chance for success. This included treating Sein with triple-therapy immu- nosuppression after the procedure. "Her postoperative course a nd her healing went extremely well," Dr. Genden says. "I was beyond pleased." One thing is certain. The procedure not only saved Sein's life, but it gave her back the ability to enjoy being alive. "I'm able to dance with my grandkids for the first time in six years," Sein told Mount Sinai. "So that's the best thing this transplant has given me, to be able to do those little things, playing with them and just having a good time. And laughing. I haven't done that in a long time." THE FUTURE OF TRACHEAL TRANSPLANTS W h i le t he f i r s t i n-hu m a n t ra chea l tra nspla nt wa s a n unequivoca l suc- cess, Dr. G enden rea lizes t hat it w i l l t a k e t i m e b e for e t h e pr o c e du r e i s widely performed. "At this point, we're not sure where it fits in. And we have to figure that out," he says. "We do know that for right now, this is for the very ill: patients that have no other options and are otherwise rela- tively healthy." In the future, he foresees the procedure helping patients with many different conditions, including chi ldren w it h tracheal birth defects and patients with trachea-esophageal fistula deficits and other diseases. The procedure also holds promise for COV ID-19 patients with damage to the trachea from intubation or the disease itself. "Being widely and broadly applied is critically important if the procedure is going to become an important option for patients who need this kind of work," Dr. Genden says, noting that the sur- gery is something most microvascular surgeons can learn. "As it starts to work itself through the medical and surgical communities, time will tell, but it doesn't require a lot more training or specific training. It just requires understanding the technique." Dr. Genden says one of the most import- ant lessons he has learned is that it is sometimes necessary to challenge dogma in medicine. " We're trained to move a head with what's already been discovered, but taking a moment to step back and ask, 'Is there a better way to do this?' is really important," he says. "I didn't do this to pose a challenge or be disrespectful. It was simply scientific curiosity and asking the question. I think that's healthy." n To learn more, visit mountsinai.org/care/ent/services/tracheal-transplant/program. Director of the Recanati/Miller Transplant Institute Sander S. Florman, MD, tracheal transplant recipient Sonia Sein, Dr. Genden and Director of Bronchoscopy at the Mount Sinai – National Jewish Health Respiratory Institute, Timothy Harkin, MD 1 0❱❱❱❱❱ C O V E R F E A T U R E

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - August/September 2021